- Home
- ATNF
as 12-23-2024 4:00pm EST
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | 2.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 127.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.16 - $17.75 | Next Earning Date: | 02-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 54.15% |
Latest 180 Life Sciences Corp. News
ATNF Breaking Stock News: Dive into ATNF Ticker-Specific Updates for Smart Investing
ACCESSWIRE
12 days ago
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
ACCESSWIRE
20 days ago
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
ACCESSWIRE
2 months ago
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
ACCESSWIRE
2 months ago
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
GlobeNewswire
2 months ago
Elray Resources Announces Strategic Sale of Crypto iGaming Technology
GuruFocus.com
2 months ago
180 Life Sciences' Brave Decision To Switch to the iGaming Industry
ACCESSWIRE
2 months ago
180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
ACCESSWIRE
2 months ago
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
Compare ATNF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATNF 180 Life Sciences Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.